SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-006784
Filing Date
2021-01-12
Accepted
2021-01-12 07:31:02
Documents
12
Period of Report
2021-01-12
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d103125d8k.htm   iXBRL 8-K 377132
  Complete submission text file 0001193125-21-006784.txt   529397

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA eidx-20210112.xsd EX-101.SCH 3054
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE eidx-20210112_lab.xml EX-101.LAB 18887
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eidx-20210112_pre.xml EX-101.PRE 11849
5 EXTRACTED XBRL INSTANCE DOCUMENT d103125d8k_htm.xml XML 3454
Mailing Address 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104
Business Address 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104 650-391-9740
Eidos Therapeutics, Inc. (Filer) CIK: 0001731831 (see all company filings)

IRS No.: 463733671 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38533 | Film No.: 21522418
SIC: 2834 Pharmaceutical Preparations